Notably, a circuit consisting of CRISPRa and such an improved p53-sensing NOT gate (PM2-ACRmax) enabled selective output production in the p53-deficient tumor cells even under basal culture conditions (Fig. 4). Here, TP53 is linked to neoplasm.